A signature of immune function genes associated with recurrence-free survival in breast cancer patients. - Wikidata - wikimedia - TriplyDB

A signature of immune function genes associated with recurrence-free survival in breast cancer patients.

A signature of immune function genes associated with recurrence-free survival in breast cancer patients.

http://www.wikidata.org/entity/Q36199789

about

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy Therapeutic cancer vaccines: past, present, and future Bioinformatics for cancer immunology and immunotherapy The STING pathway and the T cell-inflamed tumor microenvironment An immunologic portrait of cancer Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes The stable traits of melanoma genetics: an alternate approach to target discovery Dual roles for immune metagenes in breast cancer prognosis and therapy prediction.Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer.A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Distinct signatures of the immune responses in low risk versus high risk neuroblastoma Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.miR-30e* is an independent subtype-specific prognostic marker in breast cancer Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes A genetic inference on cancer immune responsiveness Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis Cooperativity of adaptive and innate immunity: implications for cancer therapy.Profiling the immune stromal interface in breast cancer and its potential for clinical impact Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients.CD4⁺ follicular helper T cell infiltration predicts breast cancer survival IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance.Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.Immunotherapy of cancer: reprogramming tumor-immune crosstalk.Immunotherapy strategies in the treatment of breast cancer.Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.Immune biomarkers: how well do they serve prognosis in human cancers?Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology.Immunotherapy for the treatment of breast cancer.Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.

P2860

Q26798404-09DD4329-E42E-4350-9346-04D595C047F2 Q26863283-C5A1AA70-F773-4E0F-BDCB-9A8DFA149EF8 Q26864876-51D7FC11-1A1C-45BF-949B-5F92674C293D Q27008371-4AC80291-FF72-42F9-B888-D1D32B7A95E5 Q27028000-A28709F4-E8D1-4A56-8E79-2420E276F902 Q28078361-8D02D4A3-04A0-4236-88FC-DE73976A3088 Q30274920-8602698B-B03D-4150-AAB5-3BEF4356697C Q30423599-0477E720-0503-4987-9068-7665ED2C06FA Q33750137-AEBE41C9-9A31-4204-92EA-927F3373C423 Q33814856-2601D2EA-FA0E-4D7F-93CA-C6C2F514C0F1 Q34248355-48B7830D-38DA-4C73-98F2-862DB9F7FF3B Q34558758-F8EF56DC-986B-4436-A364-E4EA966EA8BA Q35009369-585E7F0B-D8CD-4444-9ABD-48AEC99ABD0C Q35274995-9AFE7981-C257-4EF1-BB31-E520356F2825 Q35373780-4DA32606-1C29-4BE8-9D65-CEC2065DA77F Q35541507-2C934912-AEA4-4CAF-B058-6F24F00B60A0 Q35863168-55517CA5-DD56-47F7-9DF2-E4AD99F8CD57 Q36000900-AEE74B7B-342D-47D7-94F6-07A508B2EA87 Q36057497-AD7BF5F8-2B0D-4315-92AA-E471EE9327B9 Q36072027-5FBB6CDC-A063-43D8-948F-44F41AFC0602 Q36253304-424FDD40-C5FB-421C-BDC2-94C0BDB98310 Q36429508-9FA198F3-3B32-4710-A182-40D7A00104F3 Q36449295-013B771C-26AC-4EC9-8210-F35BE7D28BAC Q36960012-FBC9E2A4-2DDF-4386-89B8-558160F83B3A Q36966923-43334CDE-2A69-43C4-B8AB-2C650871259D Q37003368-720514FB-D757-48C6-92EC-A7A4DF4EFD0E Q37059747-ED746EFD-5BD9-4CF9-A842-B6640CBE4E48 Q37142367-F62989A2-16A7-4852-AECD-8100887A0AED Q37279217-FDDA12E9-FEBC-45A9-AD72-0B200976CE02 Q37580494-1FD41D62-87BD-4082-90AA-FFD89C7721D1 Q37732220-82EFE920-977A-47E8-AEF3-D099AED8E931 Q38055479-8B62840F-4BF0-46F6-8991-BCC89AF04E1D Q38072812-943419A6-339B-494B-9C9C-1C557983FD5D Q38201655-35D3A3C0-75FB-4128-8DC7-5FA37D20A704 Q38258842-8DAE8A57-23CE-4E47-91FA-E222C0598923 Q38262757-C98C9281-4EBB-4C73-A676-B7B7517AC0F2 Q38323254-DCB0C095-8368-4AFF-9E89-28DC5CF2024B Q38353772-54B2207C-1F99-4CAA-8F36-11913FE532E1 Q38719813-51C64D19-60A7-4504-A47C-0E56D824751C Q38819190-97A6FB5C-51B5-4C8A-BA3F-F188BB854826

P2860

A signature of immune function genes associated with recurrence-free survival in breast cancer patients.

http://www.wikidata.org/entity/Q36199789

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A signature of immune function ...... val in breast cancer patients.

@ast

A signature of immune function ...... val in breast cancer patients.

@en

type

label

A signature of immune function ...... val in breast cancer patients.

@ast

A signature of immune function ...... val in breast cancer patients.

@en

prefLabel

A signature of immune function ...... val in breast cancer patients.

@ast

A signature of immune function ...... val in breast cancer patients.

@en

P1433

Q36199789-31AA3F8C-A044-45E6-B98C-4FDDE5ADF5A3

P1476

Q36199789-853EB32C-09B9-47A0-8A20-60E06A114E38

P2093

Q36199789-0710A933-B978-4593-B654-F47F438C7FC0

Q36199789-1D91EA52-19D6-4035-820F-CB922E714C43

Q36199789-1DC40FBE-E448-480F-A0E9-37E4D8A5577B

Q36199789-4B5ECB59-FA3B-4D7F-BD1D-53837997D808

Q36199789-5499EBA8-092E-4DA6-B29B-28115B1BC6EC

Q36199789-54B694B2-55A9-4168-B1A8-7DC899CFC573

Q36199789-762714DD-73EB-412A-8053-B23FA2A36B30

Q36199789-A8A5E531-B800-4BA9-B475-BB1967B81CFE

Q36199789-C162BDD4-9C4B-4FB7-9EAA-10D7E32B25C5

Q36199789-CEFEEC87-8DDF-4D91-B1B6-47DE738803BF

P2860

Q36199789-025EE971-B3DD-4D86-A5D1-87A814CBB4EB

Q36199789-0C7E28CE-F021-487F-84A1-8513AA3C585A

Q36199789-1BF4E23C-8CD7-4DB6-8814-5E0FCA36F0A0

Q36199789-1CE138F4-737E-4574-9E95-8728907842E9

Q36199789-245E667F-4852-4667-9792-51AD583D7D7C

Q36199789-30B1D362-EE86-4177-B15D-3804390C6D35

Q36199789-31999263-E288-4DE4-885C-88BFB91728EF

Q36199789-336C954D-87A7-4E5D-8E36-12613281EEAB

Q36199789-3C92D1F9-A5F4-4EC2-B6B5-6E9383840E85

Q36199789-41010888-139B-4B25-99C1-24D606F04CE0

P2888

Q36199789-482EFB3D-ED1F-441E-9732-88360C04A9F0

P304

Q36199789-6550E5AA-37D0-4D2D-A17C-70380E0D1D71

P31

Q36199789-EBECD4C2-B883-4BE7-8509-017DCD9A59A9

P356

Q36199789-6A42E452-8FB4-4125-910A-BE1E21F62632

P407

Q36199789-2FC2157B-8A8F-41DD-BF51-58662C70DC64

P433

Q36199789-2506E634-7BA3-4BDA-B43D-A5356D6D66BA

P478

Q36199789-F8C1C289-5264-47C9-8418-3D0E0F695700

P577

Q36199789-029C1C3F-5BA2-4C81-8CEF-A40E53878076

P5875

Q36199789-7C6E42D0-433A-4FB5-BDB4-C91494942523

P698

Q36199789-FC49236D-B1BE-4DED-B58B-0DCA5A0B7672

P932

Q36199789-B6AE7FDC-F253-4187-88F5-76CB185C293C

P356

S10549-011-1470-X

P1433

Breast Cancer Research and Treatment

P1476

A signature of immune function ...... val in breast cancer patients.

@en

P2093

Catherine Dumur

http://www.w3.org/2001/XMLSchema#string

Ena Wang

http://www.w3.org/2001/XMLSchema#string

Francesco M Marincola

http://www.w3.org/2001/XMLSchema#string

Harry D Bear

http://www.w3.org/2001/XMLSchema#string

Maciej Kmieciak

http://www.w3.org/2001/XMLSchema#string

Margaret Grimes

http://www.w3.org/2001/XMLSchema#string

Maria Libera Ascierto

http://www.w3.org/2001/XMLSchema#string

Masoud H Manjili

http://www.w3.org/2001/XMLSchema#string

Michael O Idowu

http://www.w3.org/2001/XMLSchema#string

Rose Manjili

http://www.w3.org/2001/XMLSchema#string

P2860

Selection and validation of endogenous reference genes using a high throughput approach

RNA amplification for successful gene profiling analysis.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Stromal gene expression predicts clinical outcome in breast cancer.

Analysis of gene expression data using BRB-ArrayTools.

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

Effector memory T cells, early metastasis, and survival in colorectal cancer.

P2888

s10549-011-1470-x

P304

871-880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-011-1470-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51038851

http://www.w3.org/2001/XMLSchema#string

P698

21479927

http://www.w3.org/2001/XMLSchema#string

P932

3431022

http://www.w3.org/2001/XMLSchema#string